Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04054310 · ClinicalTrials.gov registry record · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
A NA study of NASH - Nonalcoholic Steatohepatitis, sponsored by Perspectum.
- Recruiting
- Registry status
- NA
- Development phase
- 225
- Enrollment target
- 7
- Study locations
NCT04054310: Recruiting NA study of NASH - Nonalcoholic Steatohepatitis, sponsored by Perspectum.
NCT04054310 is a NA study of NASH - Nonalcoholic Steatohepatitis that is actively recruiting participants, run by Perspectum. The registered enrollment target is 225 participants, below the 254-participant average among 28 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (11% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04054310, a NA study of NASH - Nonalcoholic Steatohepatitis, is actively recruiting participants, sponsored by Perspectum.
- RECRUITING
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
- 7
- Study locations
Study Summary
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Primary Outcome
To evaluate, in patients with suspected Nash referred for Liver biopsy, the diagnostic performance of cT1 at discriminating those patients with NAS≥4 \& F≥2 from those patients without. In order to evaluate the diagnostic performance area under the receiver operative curve (AUROC) will be analysised.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Liver Multi Scan
Study Locations (7)
Virginia
- University of Virginia - Charlottesville
- Virginia Common wealth University - Richmond
Arizona
- Arizona Liver Health - Chandler
Illinois
- RUSH University Medical Center - Chicago
Indiana
- Indiana University Health - Indianapolis
New York
- Icahn School of Medicine at Mount Sinai - New York
Texas
- Liver Center of Texas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2026-02-01 |
| Phase | NA |
What NCT04054310 shows while recruiting
NCT04054310 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 254-participant average among 28 other NASH - Nonalcoholic Steatohepatitis trials with a reported enrollment target (11% lower).
The record links to 1 condition, with NASH - Nonalcoholic Steatohepatitis appearing as the primary indexed condition, and to 1 intervention - of which Liver Multi Scan is the first listed.
NCT04054310 lists 7 locations in 6 states (Virginia, Arizona, Illinois).
Frequently Asked Questions
What is clinical trial NCT04054310 about?
NCT04054310 is a clinical study titled "Non-Invasive Quantification of Liver Health in NASH (N-QUAN)". To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
What is the current status of trial NCT04054310?
This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2020-08-05. Estimated completion is 2026-02-01.
What conditions does trial NCT04054310 study?
This clinical trial studies the following conditions: NASH - Nonalcoholic Steatohepatitis.
What interventions are being tested in trial NCT04054310?
The interventions under investigation include: Liver Multi Scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04054310?
This trial is sponsored by Perspectum, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04054310 being conducted?
This trial has 7 study locations across Arizona, Illinois, Indiana, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NASH - Nonalcoholic Steatohepatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04054310's enrollment target sits among peer trials
225 8th of 28 higher than 21 of 28 other NASH - Nonalcoholic Steatohepatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NASH - Nonalcoholic Steatohepatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
RECRUITING · NA
-
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
RECRUITING · NA
-
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis
ACTIVE NOT RECRUITING · NA
-
Hepatic Energy Fluxes in NASH and NAS Patients
ACTIVE NOT RECRUITING · NA
-
Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease
COMPLETED · NA
-
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
- NCT05033028 · 225 participants · Phase 3
Smartphones for Opiate Addiction Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI